Dr. Dana Lerman, CEO of Skylight Psychedelics, discusses the democratization of psychedelic therapy and the importance of proper training and support for therapists. Skylight Psychedelics offers affordable training programs for therapists and aims to provide access to medication for patients. Dr. Lerman emphasizes the need for a safe and supported environment for psychedelic experiences, highlighting the risks of unsupervised ketamine use at home. Skylight Psychedelics also focuses on incorporating lesser-known medicines, such as ayahuasca and iboga, into their training programs. Dr. Lerman expresses her support for upcoming legislation that aims to decriminalize and legalize psychedelic therapy, emphasizing the urgent need for widespread access to these treatments.
Busines Insights that Deliver Value